|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01877 JUNSHI BIO
Nominal 
30.100 -0.500 (-1.634%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 1,168,384 | 48.639% | 1,948,317 | 1,502,550 | 1,453,493 | 4,024,841 |
| Cost of Sales | (244,359) | 15.919% | (498,861) | (667,290) | (526,282) | (1,258,187) |
| Gross Profit | 924,025 | 60.629% | 1,449,456 | 835,260 | 927,211 | 2,766,654 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 2,361 | -77.333% | 19,726 | (23,484) | (47) | 342 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (25,209) | -10.686% | (35,026) | (60,484) | (71,032) | (48,463) | |
| Profit / (Loss) before Taxation | (485,947) | -29.048% | (1,359,028) | (2,489,887) | (2,675,202) | (592,648) | |
| Taxation | 19,538 | -- | (22,552) | (43,995) | 93,107 | (135,533) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 52,978 | 23.914% | 99,182 | 252,258 | 196,028 | 9,624 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (413,431) | -35.971% | (1,282,398) | (2,281,624) | (2,386,067) | (718,557) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 25,025 | -- | 7,722 | (70,420) | (31,648) | (9,146) |
| Depreciation & Amortisation | -- | -- | 283,875 | 303,220 | 263,907 | 262,559 |
| Directors' Emoluments | -- | -- | 40,585 | 55,345 | 68,691 | 102,780 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -42.000 | -36.364% | -130.000 | -232.000 | -260.000 | -80.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (1.465) | (2.045) | (1.935) | (0.719) |
| NBV per share ($) | 6.229 | -- | 5.969 | 7.275 | 9.667 | 8.741 |
| Remarks: | Real time quote last updated: 23/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -413,431 |
| %Change | -35.971% |
| EPS / (LPS) | RMB -0.420 |
| NBV Per Share (¥) | RMB 6.229 |